Skip to the page

Data / Drug companies / Metoprolol succinate

Metoprolol succinate: 46 companies and 226 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Metoprolol succinate is listed in the FDA National Drug Code Directory by 46 companies, with 226 products in commercial distribution. 212 of the products (93.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, film coated, extended release; capsule, extended release, and the newest product started marketing on July 6, 2026.

The request: Get every company that lists metoprolol succinate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
46
Products
226
Generic (ANDA) products
212 (93.8%)
Application numbers
14
Routes
Oral
Brand names
Toprol XL, Kapspargo
openFDA record search
api.fda.gov

Companies that list metoprolol succinate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions16tablet, extended release; tablet, film coated, extended releaseGeneric drugs (ANDA)October 2, 2023
Bryant Ranch Prepack15tablet, extended release; tablet, film coated, extended releaseGeneric drugs (ANDA)July 21, 2025
BluePoint Laboratories12tablet, extended releaseGeneric drugs (ANDA)March 1, 2026
Remedyrepack Inc.10tablet, extended release; tablet, film coated, extended releaseGeneric drugs (ANDA)December 9, 2025
Proficient Rx LP9tablet, film coated, extended release; tablet, extended releaseGeneric drugs (ANDA)November 6, 2020
Oryza Pharmaceuticals Inc.8tablet, extended releaseGeneric drugs (ANDA)May 15, 2026
Northwind Health Company, LLC7tablet, extended release; tablet, film coated, extended releaseGeneric drugs (ANDA)April 20, 2023
NuCare Pharmaceuticals,Inc.7tablet, extended release; tablet, film coated, extended releaseGeneric drugs (ANDA)October 2, 2023
Cardinal Health 107, LLC6tablet, film coated, extended releaseGeneric drugs (ANDA)February 24, 2025
Aphena Pharma Solutions - Tennessee, LLC5tablet, extended releaseGeneric drugs (ANDA)February 6, 2018
Proficient Rx LP5tablet, film coated, extended release; tablet, extended releaseGeneric drugs (ANDA)October 2, 2023
Redpharm Drug5tablet, film coated, extended release; tablet, extended releaseGeneric drugs (ANDA)October 2, 2023
Actavis Pharma, Inc.4tablet, film coated, extended releaseGeneric drugs (ANDA)February 3, 2020
AvPAK4tablet, film coated, extended releaseGeneric drugs (ANDA)July 25, 2018
Camber Pharmaceuticals, Inc.4tablet, film coated, extended releaseGeneric drugs (ANDA)November 6, 2020
Coupler LLC4tablet, extended releaseGeneric drugs (ANDA)July 6, 2026
Cranbury Pharmaceuticals, LLC4tablet, extended releaseGeneric drugs (ANDA)June 1, 2025
Dr. Reddy's Laboratories Inc.4tablet, film coated, extended releaseGeneric drugs (ANDA)January 13, 2026
Dr. Reddy's Laboratories Limited4tablet, film coated, extended releaseGeneric drugs (ANDA)September 10, 2012
Epic Pharma, LLC4tablet, extended releaseGeneric drugs (ANDA)February 1, 2025
Golden State Medical Supply, Inc.4tablet, extended releaseGeneric drugs (ANDA)February 6, 2018
Granules India Limited4tablet, extended releaseGeneric drugs (ANDA)August 1, 2025
Granules Pharmaceuticals Inc.4tablet, film coated, extended releaseGeneric drugs (ANDA)October 2, 2023
Ingenus Pharmaceuticals, LLC4tablet, extended releaseGeneric drugs (ANDA)February 6, 2018
Melinta Therapeutics, LLC4tablet, extended releaseNew drug applications (NDA)July 3, 2023
NorthStar RxLLC4tablet, film coated, extended releaseGeneric drugs (ANDA)April 10, 2023
Northwind Health Company, LLC4tablet, film coated, extended release; tablet, extended releaseGeneric drugs (ANDA)September 15, 2025
PD-Rx Pharmaceuticals, Inc.4tablet, extended release; tablet, film coated, extended releaseGeneric drugs (ANDA)October 2, 2023
Preferred Pharmaceuticals Inc.4tablet, film coated, extended release; tablet, extended releaseGeneric drugs (ANDA)September 5, 2025
Quallent Pharmaceuticals Health LLC4tablet, film coated, extended releaseGeneric drugs (ANDA)July 20, 2023
Slate Run Pharmaceuticals, LLC4tablet, extended releaseGeneric drugs (ANDA)October 28, 2022
St. Mary's Medical Park Pharmacy4tablet, extended releaseGeneric drugs (ANDA)October 15, 2025
Sun Pharmaceutical Industries, Inc.4capsule, extended releaseNew drug applications (NDA)February 7, 2018
Sun Pharmaceutical Industries, Inc.4capsule, extended releaseNew drug applications (NDA)March 15, 2018
Zydus Lifesciences Limited4tablet, extended releaseGeneric drugs (ANDA)June 7, 2018
Zydus Pharmaceuticals USA Inc.4tablet, extended releaseGeneric drugs (ANDA)June 7, 2018
American Health Packaging3tablet, film coated, extended releaseGeneric drugs (ANDA)March 15, 2019
Aphena Pharma Solutions - Tennessee, LLC3tablet, film coated, extended releaseGeneric drugs (ANDA)January 13, 2026
Cipla USA Inc.3tablet, extended releaseGeneric drugs (ANDA)March 25, 2019
Major Pharmaceuticals3tablet, film coated, extended releaseGeneric drugs (ANDA)September 10, 2012
NCS HealthCare of Ky, LLC DBA Vangard Labs3tablet, extended releaseGeneric drugs (ANDA)September 10, 2012
Zhejiang Jutai Pharamceutical Co., Ltd3tablet, extended releaseGeneric drugs (ANDA)November 16, 2020
Bryant Ranch Prepack2tablet, extended releaseGeneric drugs (ANDA)June 7, 2018
Direct RX2tablet, extended releaseGeneric drugs (ANDA)January 19, 2021
PD-Rx Pharmaceuticals, Inc.2tablet, film coated, extended releaseGeneric drugs (ANDA)September 10, 2012
Proficient Rx LP1tablet, extended releaseGeneric drugs (ANDA)September 10, 2012

Dosage forms

Dosage formProductsShare
Tablet, extended release13258.4%
Tablet, film coated, extended release8638.1%
Capsule, extended release83.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)21293.8%
New drug applications (NDA)135.8%
Authorized generics (NDA)10.4%

Pharmacologic classes

ClassProducts
beta-Adrenergic Blocker226

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.